These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 18356196)

  • 21. Prevalence of Ocular Chlamydia trachomatis Infection in Amhara Region, Ethiopia, after 8 Years of Trachoma Control Interventions.
    Nash SD; Chernet A; Weiss P; Nute AW; Zerihun M; Sata E; Gessese D; Jensen KA; Ayele Z; Melak B; Zeru T; Mengistu A; Abebe A; Seife F; Tadesse Z; Callahan EK
    Am J Trop Med Hyg; 2023 Feb; 108(2):261-267. PubMed ID: 36623484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and associated factors of active trachoma among 1-9 years old children in Deguatemben, Tigray, Ethiopia, 2018: community cross-sectional study.
    Reda G; Yemane D; Gebreyesus A
    BMC Ophthalmol; 2020 Apr; 20(1):144. PubMed ID: 32293359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Community-level Association between Clinical Trachoma and Ocular Chlamydia Infection after MASS Azithromycin Distribution in a Mesoendemic Region of Niger.
    Amza A; Kadri B; Nassirou B; Cotter SY; Stoller NE; West SK; Bailey RL; Porco TC; Keenan JD; Lietman TM; Oldenburg CE
    Ophthalmic Epidemiol; 2019 Aug; 26(4):231-237. PubMed ID: 30957594
    [No Abstract]   [Full Text] [Related]  

  • 24. Population-based prevalence survey of follicular trachoma and trachomatous trichiasis in the Casamance region of Senegal.
    Harding-Esch EM; Kadimpeul J; Sarr B; Sane A; Badji S; Laye M; Sillah A; Burr SE; MacLeod D; Last AR; Holland MJ; Mabey DC; Bailey RL
    BMC Public Health; 2017 Jul; 18(1):62. PubMed ID: 28747198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of water, sanitation and hygiene interventions on active trachoma in North and South Wollo zones of Amhara Region, Ethiopia: A Quasi-experimental study.
    Tadesse B; Worku A; Kumie A; Yimer SA
    PLoS Negl Trop Dis; 2017 Nov; 11(11):e0006080. PubMed ID: 29125849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a Single Dose of Azithromycin for Trachoma in Low-Prevalence Communities.
    Wilson N; Goodhew B; Mkocha H; Joseph K; Bandea C; Black C; Igietseme J; Munoz B; West SK; Lammie P; Kasubi M; Martin DL
    Ophthalmic Epidemiol; 2019 Feb; 26(1):1-6. PubMed ID: 30543311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pgp3 seroprevalence and associations with active trachoma and ocular Chlamydia trachomatis infection in Malawi: cross-sectional surveys in six evaluation units.
    Burr SE; Hart J; Samikwa L; Chaima D; Cooley G; Martin D; Masika M; Solomon AW; Bailey RL; Kalua K
    PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007749. PubMed ID: 31658258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations between Water, Sanitation and Hygiene (WASH) and trachoma clustering at aggregate spatial scales, Amhara, Ethiopia.
    Altherr FM; Nute AW; Zerihun M; Sata E; Stewart AEP; Gessese D; Melak B; Astale T; Ayenew G; Callahan EK; Chanyalew M; Gashaw B; Waller LA; Tadesse Z; Nash SD
    Parasit Vectors; 2019 Nov; 12(1):540. PubMed ID: 31727155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of 3 years of SAFE (surgery, antibiotics, facial cleanliness, and environmental change) strategy for trachoma control in southern Sudan: a cross-sectional study.
    Ngondi J; Onsarigo A; Matthews F; Reacher M; Brayne C; Baba S; Solomon AW; Zingeser J; Emerson PM
    Lancet; 2006 Aug; 368(9535):589-95. PubMed ID: 16905023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Control of Trachoma from Achham District, Nepal: A Cross-Sectional Study from the Nepal National Trachoma Program.
    Pant BP; Bhatta RC; Chaudhary JS; Awasthi S; Mishra S; Sharma S; Cuddapah PA; Gwyn SE; Stoller NE; Martin DL; Keenan JD; Lietman TM; Gaynor BD
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004462. PubMed ID: 26871898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stopping azithromycin mass drug administration for trachoma: A systematic review.
    Mahmud H; Landskroner E; Amza A; Aragie S; Godwin WW; de Hostos Barth A; O'Brien KS; Lietman TM; Oldenburg CE
    PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009491. PubMed ID: 34237074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A rationale for continuing mass antibiotic distributions for trachoma.
    Ray KJ; Porco TC; Hong KC; Lee DC; Alemayehu W; Melese M; Lakew T; Yi E; House J; Chidambaram JD; Whitcher JP; Gaynor BD; Lietman TM
    BMC Infect Dis; 2007 Aug; 7():91. PubMed ID: 17683646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequency of Mass Azithromycin Distribution for Ocular Chlamydia in a Trachoma Endemic Region of Ethiopia: A Cluster Randomized Trial.
    Lietman TM; Ayele B; Gebre T; Zerihun M; Tadesse Z; Emerson PM; Nash SD; Porco TC; Keenan JD; Oldenburg CE
    Am J Ophthalmol; 2020 Jun; 214():143-150. PubMed ID: 32171768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted Mass Azithromycin Distribution for Trachoma: A Community-Randomized Trial (TANA II).
    Mahmud H; Haile BA; Tadesse Z; Gebresillasie S; Shiferaw A; Zerihun M; Liu Z; Callahan EK; Cotter SY; Varnado NE; Oldenburg CE; Porco TC; Lietman TM; Keenan JD
    Clin Infect Dis; 2023 Aug; 77(3):388-395. PubMed ID: 37021692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The burden of and risk factors for active trachoma in the North and South Wollo Zones of Amhara Region, Ethiopia: a cross-sectional study.
    Tadesse B; Worku A; Kumie A; Yimer SA
    Infect Dis Poverty; 2017 Oct; 6(1):143. PubMed ID: 28988540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotics for trachoma.
    Evans JR; Solomon AW
    Cochrane Database Syst Rev; 2011 Mar; (3):CD001860. PubMed ID: 21412875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How much is not enough? A community randomized trial of a Water and Health Education programme for Trachoma and Ocular C. trachomatis infection in Niger.
    Abdou A; Munoz BE; Nassirou B; Kadri B; Moussa F; Baarè I; Riverson J; Opong E; West SK
    Trop Med Int Health; 2010 Jan; 15(1):98-104. PubMed ID: 20409284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measuring Trachomatous Inflammation-Intense (TI) When Prevalence Is Low Provides Data on Infection With Chlamydia trachomatis.
    Zambrano AI; Muñoz BE; Mkocha H; Dize L; Gaydos CA; Quinn T; West SK
    Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):997-1000. PubMed ID: 28535271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ribosomal RNA evidence of ocular Chlamydia trachomatis infection following 3 annual mass azithromycin distributions in communities with highly prevalent trachoma.
    Keenan JD; Ayele B; Gebre T; Moncada J; Stoller NE; Zhou Z; Porco TC; McCulloch CE; Gaynor BD; Emerson PM; Schachter J; Lietman TM
    Clin Infect Dis; 2012 Jan; 54(2):253-6. PubMed ID: 22095569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Community risk factors for ocular Chlamydia infection in Niger: pre-treatment results from a cluster-randomized trachoma trial.
    Amza A; Kadri B; Nassirou B; Stoller NE; Yu SN; Zhou Z; Chin S; West SK; Bailey RL; Mabey DC; Keenan JD; Porco TC; Lietman TM; Gaynor BD;
    PLoS Negl Trop Dis; 2012; 6(4):e1586. PubMed ID: 22545165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.